Epidemiology, the study of diseases in populations, is essential to our understanding of
every aspect of migraine. Migraine epidemiology informs clinical care of patients, shapes …

Importance Approximately 90% of people in the US experience headache during their
lifetime. Migraine is the second leading cause of years lived with disability worldwide …

Objective To incorporate recent research findings, expert consensus, and patient
perspectives into updated guidance on the use of new acute and preventive treatments for …

Migraine is a neurological ailment that is characterized by severe throbbing unilateral
headache and associated with nausea, photophobia, phonophobia and vomiting. A full and …

Migraine is two to three times more prevalent in women than men, and women report a
longer attack duration, increased risk of headache recurrence, greater disability, and a …

Importance Ubrogepant is an oral calcitonin gene–related peptide receptor antagonist under
investigation for acute treatment of migraine. Objective To evaluate the efficacy and …

Chronic migraine has a great detrimental influence on a patient's life, with a severe impact
on socioeconomic functioning and quality of life. Chronic migraine affects 1–2% of the …

Objective To provide healthcare professionals with updated guidance in the use of novel
preventive and acute treatments for migraine in adults. Background The principles of …

Background Migraine is a common and often debilitating neurological disease. It can be
divided into episodic and chronic subforms based on the number of monthly headache days …

Migraine is a highly prevalent and disabling neurological disorder associated with a wide
range of psychiatric comorbidities. In this manuscript, we provide an overview of the link …